Role of prefrontal cortical calcium-independent phospholipase A2 in antinociceptive effect of the norepinephrine reuptake inhibitor antidepresssant maprotiline

Neuroscience

Volumn 340, Issue , 2017, Pages 91-100

  Chew, Wee Siong ^a   Shalini, Suku Maran ^a,b   Torta, Federico ^a,b   Wenk, Markus R ^a,b   Stohler, Christian ^c   Yeo, Jin Fei ^d   Herr, Deron R ^a   Ong, Wei Yi ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

antinociception; lipid mediators; noradrenaline; pain; prefrontal cortex

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CARRAGEENAN; CERAMIDE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LYSOPHOSPHATIDYLCHOLINE; MAPROTILINE; MESSENGER RNA; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; ADRENERGIC RECEPTOR AFFECTING AGENT; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; PHOSPHOLIPASE A2 GROUP VI; PLA2G6 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; GROOMING; LIPIDOMICS; MALE; MOUSE; NOCICEPTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATOSENSORY CORTEX; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; FACIAL PAIN; GENETICS; IMMUNOLOGY; METABOLISM; PAIN THRESHOLD; PHYSIOLOGY;

ADRENERGIC UPTAKE INHIBITORS; ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CARRAGEENAN; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FACIAL PAIN; GROUP VI PHOSPHOLIPASES A2; MALE; MAPROTILINE; MICE, INBRED C57BL; PAIN THRESHOLD; PREFRONTAL CORTEX; RNA, MESSENGER; SOMATOSENSORY CORTEX;

EID: 85002591689     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.10.037     Document Type: Article

References (62)

1. Aimone, L.D., Jones, S.L., Gebhart, G.F., Stimulation-produced descending inhibition from the periaqueductal gray and nucleus raphe magnus in the rat: mediation by spinal monoamines but not opioids. Pain 31 (1987), 123–136.
2. Atkinson, J.H., Slater, M.A., Wahlgren, D.R., Williams, R.A., Zisook, S., Pruitt, S.D., Epping-Jordan, J.E., Patterson, T.L., Grant, I., Abramson, I., Garfin, S.R., Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 83 (1999), 137–145.
3. Balsinde, J., Balboa, M.A., Dennis, E.A., Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J Biol Chem 272 (1997), 29317–29321.
4. Banafshe, H.R., Hajhashemi, V., Minaiyan, M., Mesdaghinia, A., Abed, A., Antinociceptive effects of maprotiline in a rat model of peripheral neuropathic pain: possible involvement of opioid system. Iran J Basic Med Sci 18 (2015), 752–757.
5. Baskin, D.S., Mehler, W.R., Hosobuchi, Y., Richardson, D.E., Adams, J.E., Flitter, M.A., Autopsy analysis of the safety, efficacy and cartography of electrical stimulation of the central gray in humans. Brain Res 371 (1986), 231–236.
6. Basselin, M., Rosa, A.O., Ramadan, E., Cheon, Y., Chang, L., Chen, M., Greenstein, D., Wohltmann, M., Turk, J., Rapoport, S.I., Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)beta (VIA)-deficient mice. J Lipid Res 51 (2010), 3166–3173.
7. Bazan, N.G., Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J Lipid Res 50:Suppl (2009), S400–S405.
8. Benarroch, E.E., Periaqueductal gray: an interface for behavioral control. Neurology 78 (2012), 210–217.
9. Benedetti, F., Mayberg, H.S., Wager, T.D., Stohler, C.S., Zubieta, J.K., Neurobiological mechanisms of the placebo effect. J Neurosci 25 (2005), 10390–10402.
10. Cheon, Y., Kim, H.W., Igarashi, M., Modi, H.R., Chang, L., Ma, K., Greenstein, D., Wohltmann, M., Turk, J., Rapoport, S.I., Taha, A.Y., Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)beta)-knockout mice. Biochim Biophys Acta 1821 (2012), 1278–1286.
11. Christie, M.J., James, L.B., Beart, P.M., An excitatory amino acid projection from rat prefrontal cortex to periaqueductal gray. Brain Res Bull 16 (1986), 127–129.
12. Cortina, M.S., He, J., Russ, T., Bazan, N.G., Bazan, H.E., Neuroprotectin D1 restores corneal nerve integrity and function after damage from experimental surgery. Invest Ophthalmol Vis Sci 54 (2013), 4109–4116.
13. Erdinest, N., Ovadia, H., Kormas, R., Solomon, A., Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study. J Inflamm, 11, 2014, 6.
14. Farooqui, A.A., Litsky, M.L., Farooqui, T., Horrocks, L.A., Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res Bull 49 (1999), 139–153.
15. Farooqui, A.A., Ong, W.Y., Horrocks, L.A., Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58 (2006), 591–620.
16. Floyd, N.S., Price, J.L., Ferry, A.T., Keay, K.A., Bandler, R., Orbitomedial prefrontal cortical projections to distinct longitudinal columns of the periaqueductal gray in the rat. J Comp Neurol 422 (2000), 556–578.
17. Fogelholm, R., Murros, K., Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 25 (1985), 273–275.
18. Fuster JM (2008) The Prefrontal Cortex: Academic Press.
19. Hardy, S.G., Haigler, H.J., Prefrontal influences upon the midbrain: a possible route for pain modulation. Brain Res 339 (1985), 285–293.
20. Hasturk, H., Kantarci, A., Ohira, T., Arita, M., Ebrahimi, N., Chiang, N., Petasis, N.A., Levy, B.D., Serhan, C.N., Van Dyke, T.E., RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J 20 (2006), 401–403.
21. Honore, P., Kage, K., Mikusa, J., Watt, A.T., Johnston, J.F., Wyatt, J.R., Faltynek, C.R., Jarvis, M.F., Lynch, K., Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain 99 (2002), 11–19.
22. Hosobuchi, Y., Adams, J.E., Linchitz, R., Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science 197 (1977), 183–186.
23. Hsieh, G.C., Chandran, P., Salyers, A.K., Pai, M., Zhu, C.Z., Wensink, E.J., Witte, D.G., Miller, T.R., Mikusa, J.P., Baker, S.J., Wetter, J.M., Marsh, K.C., Hancock, A.A., Cowart, M.D., Esbenshade, T.A., Brioni, J.D., Honore, P., H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav 95 (2010), 41–50.
24. Ivkovic, N., Mladenovic, I., Petkoci, S., Stojic, D., TMD chronic pain and masseter silent period in psychiatric patients on antidepressive therapy. J Oral Rehabil 35 (2008), 424–432.
25. Lee, L.H., Tan, C.H., Shui, G., Wenk, M.R., Ong, W.Y., Role of prefrontal cortical calcium independent phospholipase A(2) in antidepressant-like effect of maprotiline. Int J Neuropsychopharmacol 15 (2012), 1087–1098.
26. Lindsay, P.G., Olsen, R.B., Maprotiline in pain-depression. J Clin Psychiatry 46 (1985), 226–228.
27. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔC(T)) method. Methods 25 (2001), 402–408.
28. Loggia, M.L., Berna, C., Kim, J., Cahalan, C.M., Martel, M.O., Gollub, R.L., Wasan, A.D., Napadow, V., Edwards, R.R., The lateral prefrontal cortex mediates the hyperalgesic effects of negative cognitions in chronic pain patients. J Pain 16 (2015), 692–699.
29. Lovick, T.A., Wolstencroft, J.H., Inhibitory effects of nucleus raphe magnus on neuronal responses in the spinal trigeminal nucleus to nociceptive compared with non-nociceptive inputs. Pain 7 (1979), 135–145.
30. Lucas, K.K., Svensson, C.I., Hua, X.Y., Yaksh, T.L., Dennis, E.A., Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2. Br J Pharmacol 144 (2005), 940–952.
31. Lynch, M.E., Watson, C.P., The pharmacotherapy of chronic pain: a review. Pain Res Manage 11 (2006), 11–38.
32. Manfredini, D., Guarda-Nardini, L., Winocur, E., Piccotti, F., Ahlberg, J., Lobbezoo, F., Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 (2011), 453–462.
33. Miranda, H.F., Noriega, V., Zanetta, P., Prieto, J.C., Isobolographic analysis in mice of the interaction of gabapentin and nortriptyline in relieving orofacial pain. J Orofacial Pain 27 (2013), 361–366.
34. Ng, C.H., Ong, W.Y., Increased expression of gamma-aminobutyric acid transporters GAT-1 and GAT-3 in the spinal trigeminal nucleus after facial carrageenan injections. Pain 92 (2001), 29–40.
35. Ohara, P.T., Vit, J.P., Jasmin, L., Cortical modulation of pain. Cell Mol Life Sci 62 (2005), 44–52.
36. Oliveira, A.C., Bertollo, C.M., Rocha, L.T., Nascimento, E.B. Jr., Costa, K.A., Coelho, M.M., Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma. Eur J Pharmacol 561 (2007), 194–201.
37. Ong, W.Y., Yeo, J.F., Ling, S.F., Farooqui, A.A., Distribution of calcium-independent phospholipase A2 (iPLA 2) in monkey brain. J Neurocytol 34 (2005), 447–458.
38. Park, C.K., Lu, N., Xu, Z.Z., Liu, T., Serhan, C.N., Ji, R.R., Resolving TRPV1- and TNF-alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci 31 (2011), 15072–15085.
39. Parra, A., Martos, A., Monleon, S., Carmen Arenas, M., Vinader-Caerols, C., Effects of acute and chronic maprotiline administration on inhibitory avoidance in male mice. Behav Brain Res 109 (2000), 1–7.
40. Poh, K.W., Lutfun, N., Manikandan, J., Ong, W.Y., Yeo, J.F., Global gene expression analysis in the mouse brainstem after hyperalgesia induced by facial carrageenan injection–evidence for a form of neurovascular coupling?. Pain 142 (2009), 133–141.
41. Poh, K.W., Yeo, J.F., Stohler, C.S., Ong, W.Y., Comprehensive gene expression profiling in the prefrontal cortex links immune activation and neutrophil infiltration to antinociception. J Neurosci 32 (2012), 35–45.
42. Rapoport, S.I., Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo. Prostaglandins Leukot Essent Fatty Acids 88 (2013), 79–85.
43. Reynolds, D.V., Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 164 (1969), 444–445.
44. Saarto, T., Wiffen, P.J., Antidepressants for neuropathic pain: a cochrane review. J Neurol Neurosurg Psychiatry 81 (2010), 1372–1373.
45. Sansone, R.A., Sansone, L.A., Pain, pain, go away: antidepressants and pain management. Psychiatry (Edgmont) 5 (2008), 16–19.
46. Schaeffer, E.L., Forlenza, O.V., Gattaz, W.F., Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology 202 (2009), 37–51.
47. Serhan, C.N., Petasis, N.A., Resolvins and protectins in inflammation resolution. Chem Rev 111 (2011), 5922–5943.
48. Serhan, C.N., Gotlinger, K., Hong, S., Arita, M., Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostag Other Lipid Med 73 (2004), 155–172.
49. Sessle, B.J., Dubner, R., Greenwood, L.F., Lucier, G.E., Descending influences of periaqueductal gray matter and somatosensory cerebral cortex on neurones in trigeminal brain stem nuclei. Can J Physiol Pharmacol 54 (1976), 66–69.
50. Sun, Y.P., Oh, S.F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S.P., Petasis, N.A., Serhan, C.N., Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 282 (2007), 9323–9334.
51. Tan, C.H., He, X., Yang, J., Ong, W.Y., Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline: a link between noradrenergic and glutamatergic function?. Exp Brain Res 170 (2006), 448–456.
52. Tassoni, D., Kaur, G., Weisinger, R.S., Sinclair, A.J., The role of eicosanoids in the brain. Asia Pac J Clin Nutr 17:Suppl. 1 (2008), 220–228.
53. Valet, M., Sprenger, T., Boecker, H., Willoch, F., Rummeny, E., Conrad, B., Erhard, P., Tolle, T.R., Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain–an fMRI analysis. Pain 109 (2004), 399–408.
54. Verdu, B., Decosterd, I., Buclin, T., Stiefel, F., Berney, A., Antidepressants for the treatment of chronic pain. Drugs 68 (2008), 2611–2632.
55. Von Korff, M., Dworkin, S.F., Le Resche, L., Kruger, A., An epidemiologic comparison of pain complaints. Pain 32 (1988), 173–183.
56. Vos, B.P., Strassman, A.M., Maciewicz, R.J., Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J Neurosci 14 (1994), 2708–2723.
57. Vrethem, M., Boivie, J., Arnqvist, H., Holmgren, H., Lindstrom, T., Thorell, L.H., A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 13 (1997), 313–323.
58. Wager, T.D., Expectations and anxiety as mediators of placebo effects in pain. Pain 115 (2005), 225–226.
59. Xie, Y.F., Huo, F.Q., Tang, J.S., Cerebral cortex modulation of pain. Acta Pharmacol Sin 30 (2009), 31–41.
60. Xu, Z.Z., Zhang, L., Liu, T., Park, J.Y., Berta, T., Yang, R., Serhan, C.N., Ji, R.R., Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 16 (2010), 592–597 591–597.
61. Yeo, J.F., Ong, W.Y., Ling, S.F., Farooqui, A.A., Intracerebroventricular injection of phospholipases A2 inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 112 (2004), 148–155.
62. Zhang, S., Tang, J.S., Yuan, B., Jia, H., Inhibitory effects of electrical stimulation of ventrolateral orbital cortex on the rat jaw-opening reflex. Brain Res 813 (1998), 359–366.